Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomide or Lenalinomide.
Clinical trial NCT01268774 · COMPLETED
Trial details
- NCT number
- NCT01268774
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-02-01
- Primary completion
- 2011-05-01
- Enrollment
- 529
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.